Skip to main content

NEOGENOMICS INC

For the period ended Jun 30, 2024. Filed Jul 30, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Jul 30, 2024

NEO$17.60+4.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 6. Exhibits

Exhibit NumberDescription of ExhibitLocation
31.1Certification by Principal Executive Officer pursuant to Rule 13a-14(a)/ 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002Provided herewith.
31.2Certification by Principal Financial Officer pursuant to Rule 13a-14(a)/ 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002Provided herewith.
32.1Certification by Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002Provided herewith.
101.INSXBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)Provided herewith.
101.SCHXBRL Taxonomy Extension Schema DocumentProvided herewith.
101.CALXBRL Taxonomy Extension Calculation Linkbase DocumentProvided herewith.
101.DEFXBRL Taxonomy Extension Definition Linkbase DocumentProvided herewith.
101.LABXBRL Taxonomy Extension Labels Linkbase DocumentProvided herewith.
101.PREXBRL Taxonomy Extension Presentation Linkbase DocumentProvided herewith.
104Cover Page Interactive File (formatted as inline XBRL and contained within Exhibit 101)Provided herewith.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.